Summary & Overview
CPT 90653: Inactivated Influenza Vaccine, Subunit with Adjuvant
CPT code 90653 denotes an inactivated influenza vaccine formulation composed of viral subunits combined with an adjuvant to boost immune response and is administered via a separately reportable intramuscular injection. This code identifies a specific vaccine product important for seasonal influenza prevention, especially in populations prioritized for enhanced immunogenicity. Nationally, accurate coding for adjuvanted influenza vaccines matters for public health monitoring, supply management, and payer reimbursement consistency.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for adjuvanted, inactivated influenza vaccines, typical sites of service where administration occurs, and the service type classification. The publication outlines coding benchmarks, payer coverage considerations, and relevant policy or billing updates where available. It also highlights common modifier use and coding caveats related to separately reportable intramuscular vaccine administration.
This resource is intended to help billing managers, clinicians, and policy analysts understand the clinical and administrative implications of reporting CPT code 90653 for influenza immunization services across major national payers. Data not available in the input: specific payer policies, reimbursement rates, associated taxonomies, and ICD-10 diagnosis pairings.
Billing Code Overview
CPT code 90653 represents an inactivated influenza vaccine that contains viral subunits and an adjuvant to enhance the immune response. The product is supplied for administration as a separately reportable intramuscular injection.
Service type: Vaccine administration (intramuscular), immunization product
Typical site of service: Outpatient clinics, physician offices, community clinics, and other ambulatory care settings where intramuscular vaccinations are provided
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to a primary care clinic during influenza season for routine immunization. The clinician reviews the patients medical history for vaccine contraindications, documents informed consent and prior influenza vaccinations, and administers an intramuscular dose of an inactivated, adjuvanted influenza vaccine. The vaccine is drawn from a single-dose vial and given in the deltoid using standard infection control technique. Post-vaccination observation for 15 minutes is conducted to monitor for immediate adverse reactions. Immunization details (vaccine brand if known, lot number, expiration date, route, site, and dose) are recorded in the medical record and the state immunization registry. Billing is submitted using 90653 for the vaccine product with an appropriate modifier if required for payer reporting, medical record documentation, or unusual circumstances such as an adverse event or split/shared services.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management (E/M) service by the same physician on the same day | Use when a documented E/M visit is provided in addition to the vaccine administration. |
59 |